Cyclin E2 is the predominant E-cyclin associated with NPAT in breast cancer cells

被引:0
|
作者
Samuel Rogers
Brian S Gloss
Christine S Lee
Claudio Marcelo Sergio
Marcel E Dinger
Elizabeth A Musgrove
Andrew Burgess
Catherine Elizabeth Caldon
机构
[1] The Kinghorn Cancer Centre and Cancer Research Program,
[2] Garvan Institute of Medical Research,undefined
[3] St Vincent’s Clinical School,undefined
[4] Faculty of Medicine UNSW,undefined
[5] Wolfson Wohl Cancer Research Centre,undefined
[6] University of Glasgow,undefined
[7] Garscube Estate,undefined
来源
Cell Division | / 10卷
关键词
Cyclin E1; Cyclin E2; CDK2; Centrosome; Cajal bodies; Histone Locus bodies (HLB); Spliceosomes; NPAT; Histones; Breast cancer;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 50 条
  • [21] Prognostic significance of cyclin E in breast cancer
    Potemski, Piotr
    Kordek, Radzislaw
    ONCOLOGY IN CLINICAL PRACTICE, 2005, 1 (02): : 76 - 82
  • [22] Cyclin E expression and proliferation in breast cancer
    Nielsen, NH
    Arnerlöv, C
    Cajander, S
    Landberg, G
    ANALYTICAL CELLULAR PATHOLOGY, 1998, 17 (03): : 177 - 188
  • [23] Cyclin E2 is required for embryogenesis in Xenopus laevis
    Gotoh, Tetsuya
    Shigemoto, Noriko
    Kishimoto, Takeo
    DEVELOPMENTAL BIOLOGY, 2007, 310 (02) : 341 - 347
  • [24] Cytoplasmic Cyclin E and Phospho-Cyclin-Dependent Kinase 2 Are Biomarkers of Aggressive Breast Cancer
    Karakas, Cansu
    Biernacka, Anna
    Bui, Tuyen
    Sahin, Aysegul A.
    Yi, Min
    Akli, Said
    Schafer, Jolie
    Alexander, Angela
    Adjapong, Opoku
    Hunt, Kelly K.
    Keyomarsi, Khandan
    AMERICAN JOURNAL OF PATHOLOGY, 2016, 186 (07): : 1900 - 1912
  • [25] Cyclin E and survival in patients with breast cancer.
    Keyomarsi, K
    Tucker, SL
    Buchholz, TA
    Callister, M
    Ding, Y
    Hortobagyi, GN
    Bedrosian, I
    Knickerbocker, C
    Toyofuku, W
    Lowe, M
    Herliczek, TW
    Bacus, SS
    NEW ENGLAND JOURNAL OF MEDICINE, 2002, 347 (20): : 1566 - 1575
  • [26] Cyclin E overexpression correlates with inflammation in breast cancer
    Howe, Tiffany M.
    Boersma, Brenda J.
    Goodman, Julie E.
    Yfantis, Harry G.
    Cottrell, John R.
    Prueitt, Robyn L.
    Bowman, Elise D.
    Lee, Dong H.
    Ambs, Stefan
    CANCER RESEARCH, 2006, 66 (08)
  • [27] Cyclin E and prognosis in patients with breast cancer.
    Sutherland, RL
    Musgrove, EA
    NEW ENGLAND JOURNAL OF MEDICINE, 2002, 347 (20): : 1546 - 1547
  • [28] Cyclin E as a prognostic and predictive marker in breast cancer
    Hunt, KK
    Keyomarsi, K
    SEMINARS IN CANCER BIOLOGY, 2005, 15 (04) : 319 - 326
  • [29] DEREGULATION OF CYCLIN-E IN BREAST-CANCER
    KEYOMARSI, K
    CONTE, D
    TOYOFUKU, W
    FOX, MP
    ONCOGENE, 1995, 11 (05) : 941 - 950
  • [30] Cyclin E1, but not Cyclin E2 is required for efficient liver regeneration in Cdk2-deficient mice
    Hu, Wei
    Nevzorova, Yulia A.
    Haas, Ute
    Sicinski, Peter
    Barbacid, Mariano
    Trautwein, Christian
    Liedtke, Christian
    HEPATOLOGY, 2012, 56 : 244A - 244A